Cargando…
Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A)
Glaucoma is a complex, multifactorial optic neuropathy mainly characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, resulting in a decline of visual function. The pathogenic molecular mechanism of glaucoma is still not well understood, and therapeutic strategies spe...
Autores principales: | Schmelter, Carsten, Fomo, Kristian Nzogang, Brueck, Alina, Perumal, Natarajan, Markowitsch, Sascha D., Govind, Gokul, Speck, Thomas, Pfeiffer, Norbert, Grus, Franz H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377047/ https://www.ncbi.nlm.nih.gov/pubmed/37509196 http://dx.doi.org/10.3390/biom13071161 |
Ejemplares similares
-
Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy
por: Schmelter, Carsten, et al.
Publicado: (2019) -
Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
por: Fomo, Kristian Nzogang, et al.
Publicado: (2022) -
Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues
por: Schmelter, Carsten, et al.
Publicado: (2021) -
Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2016) -
The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice
por: Chemnitz, Jan, et al.
Publicado: (2019)